Vir Biotechnology Competitors and Similar CompaniesClear all
Vir Biotechnology's competitors and similar companies include Kalaris Therapeutics and Imaxio.
 Vir Biotechnology Vir Biotechnology is a biopharmaceutical company that develops therapies for infectious diseases and cancer. |  Kalaris Therapeutics Kalaris Therapeutics (formerly known as AlloVir and ViraCyte) is a company that develops and delivers transformative cell therapies for patients suffering from life-threatening virus-associated diseases. |  Imaxio Imaxio is a biotech company specializing in vaccinology and in human leptospirosis prophylaxis. | |
Founding Date | Founding Date 2016 | Founding Date 2013 | Founding Date 2000 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations San Francisco, US HQ Bellinzona, CH | Locations Waltham, US HQ Dublin, IE Milan, IT | Locations Paris, FR HQ Lyon, FR |
Employees | Employees 40830% decrease | Employees 695% decrease | Employees 23 |
Valuation ($) | Valuation ($) 1 b | Valuation ($) 103.1 m | Valuation ($) N/A |
Financial | |||
Net income | Net income ($438m) (FY, 2025) | Net income ($43.4m) (FY, 2025) | Net income N/A |
Operating ⚠ | |||
Patents (US) | Patents (US) 1 (Oct, 2019) | Patents (US) 2 (Jul, 2020) | Patents (US) N/A |
Funding | |||
Total funding raised | Total funding raised $ 637.7m | Total funding raised $ 159m | Total funding raised $ 3.8m |
For sources of this data, please see the company profile
View Company Profiles
Kalaris Therapeutics
HQ
Waltham, US
Employees
6
Kalaris Therapeutics (formerly known as AlloVir and ViraCyte) is a company that develops and delivers transformative cell therapies for patients suffering from life-threatening virus-associated diseases.
View companyImaxio
HQ
Paris, FR
Imaxio is a biotech company specializing in vaccinology and in human leptospirosis prophylaxis.
View company